Opportunity ID: 105953
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-11-033 |
| Funding Opportunity Title: | Collaborating Centers of Excellence in Regulatory Science and Innovation (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | CategoryExplanation |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health Information and Statistics Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.103 — Food and Drug Administration_Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 15, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 15, 2011 |
| Current Closing Date for Applications: | Aug 15, 2011 |
| Archive Date: | Aug 16, 2011 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | MD and PhD granting institutions of higher education within a 50 mile radius of FDA’s Silver Spring, Maryland campus, including:
– Public/State Controlled Institutions of Higher Education -Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: -Hispanic-serving Institutions |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | As part of the FDA’s Advancing Regulatory Science Initiative, the Office of Chief Scientist supports innovation to improve the development and evaluation of new, safe, and effective medical products for diagnosing, treating, and preventing conditions and diseases.
This Funding Opportunity Announcement (FOA) will provide support for one or more Collaborating Centers of Excellence in Regulatory Science and Innovation (CERSI) in the national capitol region. The CERSI’s will be established to foster an innovative and thematically coherent approach to advance the field of regulatory science (including laboratory, population, behavioral, and manufacturing sciences) and the Critical Path Initiative toward more effective and efficient product development and evaluation. |
| Link to Additional Information: | Funding Opportunity Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Stephanie Bogan
Grants Management Specialist Email:stephanie.bogan@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Packages
| Agency Contact Information: | Stephanie Bogan Grants Management Specialist Email: stephanie.bogan@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | ADOBEFORMSB1 | AdobeFormsB1 | PKG00064810 | Jul 15, 2011 | Aug 15, 2011 | View |
Package 1
Mandatory forms
Optional forms
Share This Post, Choose Your Platform!
About the Author: osnqt
